R. Ruffin

953 total citations
29 papers, 773 citations indexed

About

R. Ruffin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, R. Ruffin has authored 29 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 5 papers in Immunology and Allergy. Recurrent topics in R. Ruffin's work include Asthma and respiratory diseases (16 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (6 papers). R. Ruffin is often cited by papers focused on Asthma and respiratory diseases (16 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (6 papers). R. Ruffin collaborates with scholars based in Australia, Canada and Ireland. R. Ruffin's co-authors include Michael T. Newhouse, Myrna Dolovich, Denis Corr, J. H. Alpers, George Obminski, J McAinsh, J.D. Fitzgerald, Ronald K. Wolff, Frederick E. Hargreave and Robert D. Hamilton and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

R. Ruffin

28 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ruffin Australia 14 493 365 63 59 52 29 773
J. Gaddie United Kingdom 14 377 0.8× 370 1.0× 118 1.9× 76 1.3× 43 0.8× 26 790
R. A. Bethel United States 17 573 1.2× 559 1.5× 19 0.3× 23 0.4× 60 1.2× 21 1.1k
Noemi M. Eiser United Kingdom 19 622 1.3× 595 1.6× 26 0.4× 64 1.1× 202 3.9× 40 1.1k
Marshall B. Dunning United States 14 602 1.2× 412 1.1× 17 0.3× 72 1.2× 15 0.3× 25 1.0k
K.N.V. Palmer United Kingdom 25 910 1.8× 612 1.7× 182 2.9× 214 3.6× 33 0.6× 88 1.6k
Graham K. Crompton United Kingdom 15 1.1k 2.2× 917 2.5× 26 0.4× 9 0.2× 38 0.7× 25 1.3k
Bruce P. Ekholm United States 18 514 1.0× 411 1.1× 95 1.5× 34 0.6× 10 0.2× 35 779
Gianluigi Poli Italy 14 520 1.1× 380 1.0× 22 0.3× 24 0.4× 12 0.2× 40 633
Richard D. Strickland United States 10 113 0.2× 98 0.3× 57 0.9× 148 2.5× 8 0.2× 29 589
Demetri Pavia United Kingdom 14 664 1.3× 364 1.0× 23 0.4× 9 0.2× 9 0.2× 24 740

Countries citing papers authored by R. Ruffin

Since Specialization
Citations

This map shows the geographic impact of R. Ruffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ruffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ruffin more than expected).

Fields of papers citing papers by R. Ruffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ruffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ruffin. The network helps show where R. Ruffin may publish in the future.

Co-authorship network of co-authors of R. Ruffin

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ruffin. A scholar is included among the top collaborators of R. Ruffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ruffin. R. Ruffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murgia, Chiara, Carol J. Lang, Ai Q. Truong-Tran, et al.. (2006). Zinc and its Specific Transporters as Potential Targets in Airway Disease. Current Drug Targets. 7(5). 607–627. 36 indexed citations
2.
Pfitzner, J., et al.. (2000). Pulmonary alveolar proteinosis: two contrasting cases. European Respiratory Journal. 15(2). 426–426. 10 indexed citations
3.
Ruffin, R., et al.. (1997). The value of the lipid‐laden macrophage index in the assessment of aspiration pneumonia. Australian and New Zealand Journal of Medicine. 27(5). 550–553. 36 indexed citations
4.
Rowett, Debra, K. M. Latimer, Lloyd Sansom, et al.. (1996). The effect of hypoxaemia on drug disposition in chronic respiratory failure. European Journal of Clinical Pharmacology. 50(1-2). 77–82. 2 indexed citations
5.
Ruffin, R. & K. M. Latimer. (1991). Lack of effect of 4 weeks of oral H1 antagonist on bronchial responsiveness. European Respiratory Journal. 4(5). 575–579. 4 indexed citations
6.
Latimer, K. M. & R. Ruffin. (1990). THE EFFECT OF INHALED FENOTEROL AND IPRATROPIUM BROMIDE ON PROPRANOLOL INDUCED BRONCHOCONSTRICTION IN THE ASTHMATIC AIRWAYS. Clinical and Experimental Pharmacology and Physiology. 17(9). 627–635. 2 indexed citations
7.
Latimer, K. M. & R. Ruffin. (1990). Bronchoconstriction of the asthmatic airway by inhaled and ingested propranolol. European Journal of Clinical Pharmacology. 39(5). 441–5. 2 indexed citations
8.
Henderson, George, et al.. (1988). Biochemical studies of N-methyltransferase in human and guinea-pig lung: no apparent role in the pathogenesis of asthma. Clinical Science. 75(1). 5–11. 1 indexed citations
9.
Ruffin, R., et al.. (1987). COMBINED BRONCHODILATOR PROTECTION AGAINST HISTAMINE‐INDUCED BRONCHOCONSTRICTION IN MAN. Clinical and Experimental Pharmacology and Physiology. 14(2). 87–94. 1 indexed citations
10.
Ruffin, R., et al.. (1986). The effect of bucindolol on the airway function of asthmatics. European Journal of Clinical Pharmacology. 30(5). 559–565. 4 indexed citations
11.
Ruffin, R., et al.. (1982). Assessment of beta‐adrenoceptor antagonists in asthmatic patients.. British Journal of Clinical Pharmacology. 13(S2). 325S–335S. 42 indexed citations
12.
Corr, Denis, et al.. (1982). Design and characteristics of a portable breath actuated, particle size selective medical aerosol inhaler. Journal of Aerosol Science. 13(1). 1–7. 72 indexed citations
13.
Ruffin, R., et al.. (1981). Repeated histamine inhalation tests in asthmatic patients. Journal of Allergy and Clinical Immunology. 67(4). 285–289. 59 indexed citations
14.
Crockett, Alan, et al.. (1981). Evaluation of Lyophilized Heparin Syringes for the Collection of Arterial Blood for Acid Base Analysis. Anaesthesia and Intensive Care. 9(1). 40–42. 4 indexed citations
15.
Hamilton, Robert D., Alan Crockett, R. Ruffin, & J. H. Alpers. (1979). Bronchial Reactivity in Western Red Cedar Induced Asthma. Australian and New Zealand Journal of Medicine. 9(4). 417–419. 2 indexed citations
16.
Dolovich, Jerry, Don Cockcroft, R. Ruffin, Barbara Bell, & Frederick E. Hargreave. (1978). 218. Serum antibody responses to experimental allergen inhalation challenges. Journal of Allergy and Clinical Immunology. 61(3). 194–194. 3 indexed citations
17.
Fitzgerald, J.D., et al.. (1978). Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. European Journal of Clinical Pharmacology. 13(2). 81–89. 107 indexed citations
18.
Hargreave, Frederick E., Donald W. Cockcroft, R. Ruffin, & Jerry Dolovich. (1978). 217. Prediction of the dose of inhaled allergen required to produce a threshold experimental asthmatic response. Journal of Allergy and Clinical Immunology. 61(3). 194–194. 4 indexed citations
19.
Cockcroft, Donald W., R. Ruffin, & Frederick E. Hargreave. (1978). Effect of Sch1000 in allergen‐induced asthma. Clinical & Experimental Allergy. 8(4). 361–372. 40 indexed citations
20.
Ruffin, R. & Michael T. Newhouse. (1978). Ipratropium bromide (Sch1000) monohydrate aerosol: Bronchodilator effect of three dose levels in asthmatics. Lung. 155(1). 141–146. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Gaddie Breakdown of academic impact, for papers by R. A. Bethel Breakdown of academic impact, for papers by Noemi M. Eiser Breakdown of academic impact, for papers by Marshall B. Dunning Breakdown of academic impact, for papers by K.N.V. Palmer Breakdown of academic impact, for papers by Graham K. Crompton Breakdown of academic impact, for papers by Bruce P. Ekholm Breakdown of academic impact, for papers by Gianluigi Poli Breakdown of academic impact, for papers by Richard D. Strickland Breakdown of academic impact, for papers by Demetri Pavia
Rankless by CCL
2026